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Abstract
There are as many as 79 million people in the U.S. with prediabetes, and their risk of developing 
type 2 diabetes is four to 12 times higher than it is for people with normal glucose tolerance. 
Although advances in diabetes treatment are still needed, there is a critical need to implement 
effective strategies to stem the current and projected growth in new cases of type 2 diabetes. RCTs 
and translation studies have demonstrated that type 2 diabetes can be prevented or delayed in those 
at high risk, through a structured lifestyle intervention that can be delivered cost effectively. In 
order to bring this compelling lifestyle intervention to communities across America, Congress 
authorized the CDC to establish and lead the National Diabetes Prevention Program. Several 
aspects of the etiology of type 2 diabetes suggest that strategies addressing both those at high risk 
and the general population are necessary to make a major impact on the diabetes epidemic.
Introduction
Diabetes affects almost 26 million Americans.1 Currently one in nine U.S. adults has 
diabetes, and the CDC estimates that as many as one in five could have the disease by 2025 
if current trends continue.2 As many as 79 million people in the U.S. have prediabetes,1 
representing more than one third of adult Americans and half of all adults aged ≥65 years. 
The yearly incidence of type 2 diabetes is 5%–10% in people with prediabetes, compared to 
about 1% per year in the general adult population.3
The implications of increased diabetes prevalence are extensive, because of the well-known 
risks of cardiovascular disease, vision loss, amputation, end-stage renal disease (ESRD), 
disability, and mortality.1 It is promising that the U.S. National Diabetes Surveillance 
System has documented several important improvements in diabetes complications for the 
average person with diabetes.4 The rates of amputations have declined by more than half 
since the mid-1990s, from a peak of nine per 1000 in 1996 to three per 1000 in 2009.5 
Similarly, annual rates of ESRD declined from 3.1 to 1.9 cases per 1000 between 1995 and 
2008.6 However, as the average risk of major diabetes-related complications has declined, 
rising prevalence of diabetes has increased the risk of these complications in the total 
population.7 Overall, national diabetes surveillance data make it clear that advances in 
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diabetes treatment are still needed because of the continued high rates of diabetes 
complications, but there is an equal need to implement primary prevention efforts to stem 
the current and projected growth in new cases of type 2 diabetes.
The current article summarizes the evidence for lifestyle change programs to prevent or 
delay type 2 diabetes and describes the National Diabetes Prevention Program (National 
DPP) that has been constructed based on this evidence. The National DPP provides a critical 
opportunity to organize lifestyle prevention efforts in the country in order to reduce the 
incidence of type 2 diabetes. In addition, strategies addressing the general population are 
discussed because it is likely that these must also be undertaken to make a major impact on 
trends in the diabetes epidemic.
Evidence for Lifestyle Change Prevention Programs
Fortunately, it is now well established that type 2 diabetes can be prevented or delayed in 
high-risk adults. At least five major RCTs, conducted in the U.S., China, Finland, Japan, and 
India, have documented 30%–60% reductions in diabetes incidence in high-risk adults.8–10 
At least three of the RCTs have conducted additional follow-up measurements of 
participants to examine the extended, “legacy” effect of the interventions long after the 
intervention has ended.
The Finnish Diabetes Prevention Study found a significant 43% reduction in diabetes 
incidence 3 years after the completion of the trial.11 The Da Qing diabetes prevention study 
found a 43% reduction 14 years following the intervention (20 years after baseline).12 Most 
recently, the Diabetes Prevention Program (DPP) study reported a 24% reduced incidence 8 
years following the completion of the trial (10 years after baseline).13 In the only trial to 
examine the effects on long-term complications of diabetes, Gong et al.14 found a significant 
reduction in incidence of severe retinopathy associated with the intervention.
Successful RCTs of the impact of lifestyle intervention on type 2 diabetes incidence have 
several key elements in common. All were conducted among adults with impaired glucose 
tolerance and/or impaired fasting glucose. Each study consisted of relatively intensive one-
on-one or small-group intervention using a structured curriculum for 6 months to 1 year, and 
included an extended “maintenance” period to prevent and manage relapses and encourage 
sustained behavior change.
Each major intervention achieved substantial reductions in total dietary intake, total and 
saturated fat intake, and achieved increases in leisure-time physical activity, and in some 
cases, increased fiber intake. Each study integrated behavioral principles and self-
monitoring using diet and exercise diaries to assist behavior change. Weight loss after 1 year 
in these trials ranged from 0 to 7 kg per year. The DPP, the largest efficacy trial in diabetes 
prevention, showed that people with impaired glucose tolerance who lost 5%–7% of their 
body weight and achieved 150 minutes of moderate physical activity per week through a 
structured lifestyle change program reduced their chance of getting type 2 diabetes by 16 
percentage points per year.8
Albright and Gregg Page 2













The RCTs have provided invaluable information to guide practical implementation, but they 
also included elements that pose challenges to achieve the same results in the broader 
prediabetes population and economic sustainability. For example, the DPP lifestyle 
intervention included one-on-one “core” sessions delivered by highly credentialed research 
staff. The core sessions were followed by twice-monthly in-person “maintenance” sessions 
and telephone contact between sessions.
In addition, participants were given several lifestyle modification tools including access to 
exercise facilities and meal replacements. The cost to deliver the DPP lifestyle intervention 
in the first year was $1400 per participant, an expense too great to be scaled in a sustainable 
manner.15 As efforts are made to reduce the cost of diabetes prevention, it is important to 
not lose sight of the fact that in 2007 the annual per capita healthcare expenditure for a 
person with diabetes was $11,700.16
A major focus of subsequent research for type 2 diabetes prevention has been how best to 
use limited resources to deliver the lifestyle intervention, while ensuring that weight loss is 
adequate to decrease future cases of type 2 diabetes. Several published research studies, 
carried out in real-world settings, have implemented modified versions of the lifestyle 
intervention used in the DPP research study. Ali and colleagues17 conducted a systematic 
review and meta-analysis of 28 U.S.-based studies that adapted the DPP lifestyle 
intervention in real-world settings at lower cost.17 Because the DPP study established that 
weight loss was the single most important factor in reducing type 2 diabetes incidence, Ali 
et al. examined the weight loss achieved in these translation studies. They also examined 
program characteristics that influence weight loss and cost, including number of core 
sessions and type of intervention staff.
The studies took place in diverse settings, including community centers, recreation centers, 
faith-based organizations, and healthcare facilities; four studies used electronic media. In 
total, 3797 participants were enrolled in interventions, and of these, 2916 participants had 
complete follow-up data and were included in the analysis. Mean weight change across all 
studies was about 4% at the 12-month follow-up. A 4% weight loss might seem modest, but 
it is only slightly less than what was achieved in the most-effective RCTs.18
Change in weight was similar regardless of whether the intervention was delivered by 
medical and allied health professional or lay community personnel.17 The number of core 
sessions attended was strongly correlated with the number of core sessions offered. There 
was a dose–response association between the number of sessions and amount of weight loss, 
such that there was a 1% greater weight loss for every four sessions attended. Qualitative 
information from studies included in the analysis indicated that attrition was not related to 
program length, but was related to the effectiveness of behavioral modification techniques 
and participants’ perceptions of how likely they were to develop type 2 diabetes.
National Diabetes Prevention Program
Moving diabetes prevention from research to implementation in communities is a major 
undertaking. A concerted focus on building the infrastructure for and delivery of the adapted 
DPP lifestyle change program had not been done in the U.S. until 2010 when Congress 
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authorized the CDC to establish and lead the National DPP. The National DPP is more than 
a program. It represents an approach to increase a low-cost intervention based on the DPP in 
communities across America. Its foundation is a results-driven partnership that includes 
community-based organizations, health insurers, employers, healthcare systems, academia, 
and government agencies. By serving as the backbone for bringing this effective lifestyle 
intervention across the country, the National DPP puts in place the elements for reaching the 
large-scale implementation necessary to reduce the incidence of type 2 diabetes. The CDC’s 
strategic approach to the National DPP has the following four core elements, each of which 
is discussed below, and is summarized in Figure 1: training, recognition program, lifestyle 
change program sites and payment model, and health marketing.
Training
A trained workforce that can deliver the lifestyle change program cost effectively is 
necessary. The number of people with prediabetes requires that the workforce be expanded 
to meet the demand. As demonstrated in the meta-analysis by Ali et al.,17 health 
professionals and lay community workers can effectively deliver the lifestyle change 
program.
In response to this training need, the CDC established the Diabetes Training and Technical 
Assistance Center (DTTAC) at Emory University (www.dttac@emory.edu). The DTTAC 
provides comprehensive training services across the country for lifestyle coaches to prepare 
them to effectively deliver the lifestyle change program. Following in-person training, the 
DTTAC provides an ongoing learning community that features webinars and conference 
calls with program experts and opportunities to share information and exchange best 
practices. Other organizations conduct training, and those who chose to use these other 
services should examine them to be sure they provide a level of training that will allow an 
organization’s lifestyle change program to meet CDC recognition program standards.
Recognition Program
The CDC Diabetes Prevention Recognition Program (DPRP) is a key component of the 
National DPP. The objectives of the DPRP are to (1) ensure the quality, consistency, and 
broad dissemination of the lifestyle change program for people at high risk for type 2 
diabetes; (2) develop and maintain a registry of organizations that are recognized for their 
ability to deliver an effective lifestyle change program; and (3) provide technical assistance 
to organizations that have applied for recognition to help them deliver an effective lifestyle 
change program and achieve and maintain recognition. The DPRP Standards (required 
components for type 2 diabetes prevention lifestyle change programs) are used to ensure 
consistent quality which can help individuals at risk in deciding to participate, healthcare 
professionals considering whether to refer a patient, or an insurance provider considering 
whether to pay for the program. The CDC is responsible for the DPRP, and there is no cost 
to apply for recognition. For more information about the DPRP or to apply for recognition, 
go to www.cdc.gov/diabetes/prevention/recognition.
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Lifestyle Change Program Sites and Payment Model
The most prominent core element of the National DPP is delivery of the lifestyle change 
program. The program is being offered at many locations, including community-based 
organizations, worksites, and healthcare facilities. Several of these sites have recently 
completed the application process for program recognition.
Payment is a critical component to ongoing delivery of the lifestyle change program. The 
Nation’s largest private health insurer—United Health Group (UHG)—and largest lifestyle 
program provider—the YMCA (Y is now the preferred usage)—were the first organizations 
to formally partner with the CDC in the National DPP. The Y and UHG (under the Diabetes 
Prevention and Control Alliance [DPCA]) represent a new model for sustainable delivery of 
the lifestyle change program. The Y is receiving payment on a pay-for-performance basis 
from the UHG, self-funded employers, and other insurers who purchase services through 
DPCA. In this model, UHG serves as not only an insurance provider but also a service 
provider that created and operates the technology, business processes, and infrastructure that 
support participant identification, engagement, and enrollment. The CDC is working to 
bring more partners into the National DPP, including more organizations to deliver the 
lifestyle change program and other insurers to cover the cost of participation.
Health Marketing
Even the best lifestyle change programs will not succeed without adequate uptake. National 
DPP partners are working on strategies to increase referrals to and participation in lifestyle 
change programs. Various participant engagement strategies are being evaluated, as well as 
methods to increase healthcare professionals’ understanding and support of the lifestyle 
change program. To obtain the most current information about the National DPP, visit 
www.cdc.gov/diabetes/prevention.
Tiered Approach to Prevention
Debates about optimal prevention strategies for chronic diseases often center around the 
merits of “high-risk” versus “population-wide” approaches.19,20 Approaches directed to 
those at high risk typically include a process of screening and identification of people with a 
high probability of developing a condition. This identification of high risk allows preventive 
services to be reserved for and directed to people most likely to benefit.
A population approach aims to shift the entire distribution of a risk factor in a healthy 
direction, even if just by a small degree, to have a large effect on the proportion who 
develop disease. Several aspects of the etiology and evidence base for type 2 diabetes 
prevention suggest that both high-risk and population approaches are necessary to make a 
major impact on trends in the diabetes epidemic. Further, these combined strategies will 
have an optimal effect if they are implemented as part of a multi-tiered approach that links 
the type and intensity of the intervention to the appropriate level of risk while at the same 
time altering the hazardous cultural, environmental, and economic conditions that underlie 
risk factors for type 2 diabetes.
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The most-appropriate tiers, risk indicators, and corresponding interventions remain a rapidly 
evolving area of science.21 However, epidemiologic and intervention studies point to four 
natural tiers (Table 1). At the first tier, adults with fasting plasma glucose (FPG) >110 
mg/dL; HbA1c levels >5.7%; 2-hour glucose >140 mg/dL; a history of gestational diabetes; 
or a predicted 10-year diabetes incidence of 30% or more are particularly good candidates 
for structured lifestyle interventions in community settings as described in the National DPP, 
owing to their very high risk and potential to benefit. People who do not meet criteria for 
“very high risk,” yet have FPG >100 or a predicted risk of at least 20% over 10 years, are 
also reasonable candidates for community-based lifestyle interventions, although the cost 
effectiveness of selecting them for intervention may not be as high as it is for the group that 
is at very high risk.22
These top two risk tiers for people who receive particular prioritization of structured lifestyle 
programs are warranted by several observations. First, the majority of cases of type 2 
diabetes over a 5–10-year period occur among those with hyperglycemia or a clustering of 
several major risk factors, such as obesity, hypertension, increased age, and history of 
gestational diabetes.21,23 Second, the strongest and clearest evidence for diabetes prevention 
comes from RCTs conducted among people with impaired glucose tolerance. By contrast, 
no major RCTs have examined and demonstrated the impact of diabetes prevention among 
those with normal glucose tolerance.
Third, there is a consistent dose–response relationship between the amount of lifestyle 
intervention support one is given and the magnitude of risk reduction, and results are best 
when long-term maintenance is provided.17 Even though effective lifestyle interventions can 
be delivered at relatively low costs, particularly in community settings, this dose–response 
relationship means that optimal impact still requires enough resources in terms of personnel, 
time, and facilities, and that provision of such services to anyone regardless of risk level 
makes poor economic sense. This point is portrayed in recent analyses showing that 
structured lifestyle intervention programs are more cost effective when applied to high-risk 
adults than when applied to those of moderate or low risk.22 This is mainly because using 
overly inclusive screening criteria for diabetes prevention programs leads to the use of 
services on many people who would not go on to develop diabetes even in the absence of the 
intervention.
A large segment of the population is likely to have a “moderate,” or higher than average, 
future risk of diabetes based on the presence of two or more risk factors, such as a family 
history of diabetes, being aged ≥45 years, having hypertension, or central or overall obesity, 
which makes up a third tier. Although these individuals may present no evidence of 
hyperglycemia, better awareness and brief education or counseling about how they can 
influence their risk may help to reduce progression to higher levels of risk.23,24 A fourth tier 
of people at below-average risk can be defined as a 10-year risk of less than 10%. 
Population-targeted approaches, including innovative approaches to change the food, social, 
built environment, or economic factors underlying diabetes risk or factors underlying 
obesity in the population, may benefit all four tiers regardless of risk.
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Although the clearest evidence for how to prevent type 2 diabetes comes from studies 
conducted specifically in high-risk adults, type 2 diabetes is often thought of as a common-
source epidemic that has been rooted in culture and society as much as in individual 
behaviors.25 This is evident in many of the secular trends in risk factors in the U.S. 
population, including increased portion sizes, increased caloric intake of sweetened 
beverages and refined carbohydrates, and a calorie-to-cost mismatch that has made healthy 
foods such as fruits and vegetables increase in cost more than unhealthy, energy-dense 
foods.26,27 Considerable national variation exists in the options available around the U.S., as 
many communities, both rural and urban, have poor food choices and limited options for 
physical activity.
These macro-level determinants and obesity point to opportunities to influence population 
risk by targeting the food environment, the planning of communities, as well as social and 
economic factors.25,28–31 Promising targets of the food environment that have been 
associated with diabetes risk in observational studies include approaches to increase fruit, 
vegetable, and whole-grain intake, and to reduce portion sizes and sweetened beverages.27,30 
Several strategies have been proposed for the food environment, including better food and 
menu labeling, and incentives for communities to support diverse healthy foods through 
farmers’ markets and other diverse groceries.32 Employers and schools may be key partners 
in their efforts because of their ability to alter procurement and availability of healthy foods 
and pass those options on to large segments of the population.
Although interventions that can reduce obesity in youth are unlikely to have a short-term 
payoff in diabetes incidence, they may have an important long-term impact. School-based 
nutrition and physical education policies, support of strong community-based recreation 
programs, and interventions to change advertising to youth are all promising approaches for 
youth.32 Finally, public policy approaches that are able to change the educational and 
economic status of populations should be evaluated for their potential impact on diabetes 
and other chronic diseases. As an example, a recent social experiment in which low-income 
families were randomized to receive vouchers that moved them to healthier neighborhoods 
found reduced prevalence of obesity and diabetes after 5 years.33 Such studies are rare, 
however, and are a reminder of the difficulty of demonstrating impact of policy approaches 
and the need for a broader spectrum of research to guide policies.34
Conclusion
The existing and projected burden of diabetes requires that efforts to treat diabetes continue 
to improve and that effective strategies to prevent type 2 diabetes be implemented on a large 
scale. The strongest and clearest evidence for the prevention of type 2 diabetes is from RCTs 
in which people at high risk for type 2 diabetes are exposed to a structured lifestyle 
intervention that addresses nutrition, physical activity, and behavior change strategies that 
result in modest weight loss. Several translation studies have demonstrated that the lifestyle 
intervention can be delivered more cost effectively and achieve similar weight loss.
In response to the growing incidence of type 2 diabetes and the body of evidence for type 2 
diabetes prevention in high-risk adults, Congress authorized the CDC to establish and lead 
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the National DPP. By serving as the backbone for bringing the effective lifestyle 
intervention across the country, the National DPP puts in place the necessary components of 
workforce training, quality assurance through program recognition, an effective program 
delivery and payment model, and health marketing to increase program uptake necessary for 
reducing the incidence of type 2 diabetes. Several aspects of the etiology of type 2 diabetes 
suggest that both high-risk and whole-population approaches are necessary to make a major 
impact on trends in the diabetes epidemic. These combined strategies will be more effective 
if they are implemented as a multi-tiered approach that links type and intensity of the 
intervention to the appropriate level of risk, as well as altering unhealthy cultural, 
environmental, and economic conditions that produce risk factors for type 2 diabetes.
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Summary of the four core components of the National Diabetes Prevention Program
Note: Provided by the CDC, Division of Diabetes Translation
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Table 1
Risk stratification for diabetes prevention interventions
Risk level 10-year diabetes risk, % Risk indicators Intervention
Very high 30–40 HbA1c ≥5.7% and <6.5%; FPG >110 Structured lifestyle intervention in community setting
High 20–30 FPG ≥100 mg/dL and <126 mg/dL
Moderate 10–20 2+ risk factors Risk counseling
Low   0–10 0–1 risk factor Whole-population strategies
Note: Relevant risk factors include being overweight; having a parent or sibling with diabetes; having a family background that is African-
American, Hispanic/Latino, American Indian, Asian American or Pacific Islander; a history of gestational diabetes; diagnosed hypertension; and 
sedentary lifestyle.
FPG, fasting plasma glucose; HbA1c, hemoglobin A1c
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